Hauser SL - Search Results

1

Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension.

Hauser SL, Kappos L, Arnold DL, Bar-Or A, Brochet B, Naismith RT, Traboulsee A, Wolinsky JS, Belachew S, Koendgen H, Levesque V, Manfrini M, Model F, Hubeaux S, Mehta L, Montalban X. Hauser SL, et al. Neurology. 2020 Sep 29;95(13):e1854-e1867. doi: 10.1212/WNL.0000000000010376. Epub 2020 Jul 20. Neurology. 2020. PMID: 32690791 Free PMC article.

2

Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.

Weiner HL, Mackin GA, Orav EJ, Hafler DA, Dawson DM, LaPierre Y, Herndon R, Lehrich JR, Hauser SL, Turel A, et al. Weiner HL, et al. Among authors: hauser sl. Neurology. 1993 May;43(5):910-8. doi: 10.1212/wnl.43.5.910. Neurology. 1993. PMID: 8388090 Clinical Trial.

3

Side effect profile of interferon beta-1b in MS: results of an open label trial.

Neilley LK, Goodin DS, Goodkin DE, Hauser SL. Neilley LK, et al. Among authors: hauser sl. Neurology. 1996 Feb;46(2):552-4. doi: 10.1212/wnl.46.2.552. Neurology. 1996. PMID: 8614531

4

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

Leppert D, Ford J, Stabler G, Grygar C, Lienert C, Huber S, Miller KM, Hauser SL, Kappos L. Leppert D, et al. Among authors: hauser sl. Brain. 1998 Dec;121 ( Pt 12):2327-34. doi: 10.1093/brain/121.12.2327. Brain. 1998. PMID: 9874483

5

Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group.

Hauser SL, Oksenberg JR, Lincoln R, Garovoy J, Beck RW, Cole SR, Moke PS, Kip KE, Gal RL, Long DT. Hauser SL, et al. Neurology. 2000 May 9;54(9):1859-61. doi: 10.1212/wnl.54.9.1859. Neurology. 2000. PMID: 10802800

6

Multiple sclerosis and oligodendroglioma.

Green AJ, Bollen AW, Berger MS, Oksenberg JR, Hauser SL. Green AJ, et al. Among authors: hauser sl. Mult Scler. 2001 Aug;7(4):269-73. doi: 10.1177/135245850100700410. Mult Scler. 2001. PMID: 11548988 Review.

7

The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-beta.

Villoslada P, Barcellos LF, Rio J, Begovich AB, Tintore M, Sastre-Garriga J, Baranzini SE, Casquero P, Hauser SL, Montalban X, Oksenberg JR. Villoslada P, et al. Among authors: hauser sl. J Neuroimmunol. 2002 Sep;130(1-2):194-201. doi: 10.1016/s0165-5728(02)00215-1. J Neuroimmunol. 2002. PMID: 12225902 Clinical Trial.

8

Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis.

Sriram U, Barcellos LF, Villoslada P, Rio J, Baranzini SE, Caillier S, Stillman A, Hauser SL, Montalban X, Oksenberg JR. Sriram U, et al. Among authors: hauser sl. Genes Immun. 2003 Mar;4(2):147-52. doi: 10.1038/sj.gene.6363946. Genes Immun. 2003. PMID: 12618863 Clinical Trial.

9

The HLA locus and multiple sclerosis in Sicily.

Brassat D, Salemi G, Barcellos LF, McNeill G, Proia P, Hauser SL, Oksenberg JR, Savettieri G. Brassat D, et al. Among authors: hauser sl. Neurology. 2005 Jan 25;64(2):361-3. doi: 10.1212/01.WNL.0000149765.71212.0A. Neurology. 2005. PMID: 15668443

10

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, Bar-Or A, Panzara M, Sarkar N, Agarwal S, Langer-Gould A, Smith CH; HERMES Trial Group. Hauser SL, et al. N Engl J Med. 2008 Feb 14;358(7):676-88. doi: 10.1056/NEJMoa0706383. N Engl J Med. 2008. PMID: 18272891 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

460 results

Search Page